Guardian Pharmacy Services (NYSE:GRDN) Shares Gap Up on Insider Buying Activity

Guardian Pharmacy Services, Inc. (NYSE:GRDN)’s stock price gapped up prior to trading on Thursday following insider buying activity. The stock had previously closed at $21.27, but opened at $22.04. Guardian Pharmacy Services shares last traded at $22.02, with a volume of 4,580 shares trading hands.

Specifically, Director Steven D. Cosler bought 7,000 shares of the company’s stock in a transaction dated Tuesday, November 19th. The shares were acquired at an average price of $21.22 per share, for a total transaction of $148,540.00. Following the completion of the transaction, the director now directly owns 17,713 shares in the company, valued at $375,869.86. This trade represents a 65.34 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on GRDN. Raymond James started coverage on Guardian Pharmacy Services in a research note on Monday, October 21st. They issued an “outperform” rating and a $21.00 price target on the stock. Stephens started coverage on shares of Guardian Pharmacy Services in a report on Tuesday, October 22nd. They set an “overweight” rating and a $21.00 target price for the company. Finally, Truist Financial boosted their price target on shares of Guardian Pharmacy Services from $22.00 to $24.00 and gave the stock a “buy” rating in a research report on Friday, November 15th.

Guardian Pharmacy Services Stock Performance

Guardian Pharmacy Services (NYSE:GRDN) last announced its earnings results on Tuesday, November 12th. The company reported ($2.00) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.19 by ($2.19). The firm had revenue of $314.39 million for the quarter, compared to analyst estimates of $303.21 million. On average, analysts predict that Guardian Pharmacy Services, Inc. will post 0.86 earnings per share for the current year.

Hedge Funds Weigh In On Guardian Pharmacy Services

Institutional investors and hedge funds have recently made changes to their positions in the stock. Stephens Inc. AR acquired a new stake in shares of Guardian Pharmacy Services during the third quarter valued at $189,000. Virtu Financial LLC acquired a new stake in shares of Guardian Pharmacy Services in the third quarter valued at about $279,000. Barclays PLC acquired a new position in shares of Guardian Pharmacy Services during the third quarter worth $311,000. Point72 DIFC Ltd purchased a new position in Guardian Pharmacy Services in the third quarter valued at about $573,000. Finally, Royce & Associates LP bought a new position in Guardian Pharmacy Services during the 3rd quarter valued at $1,260,000.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.